tiprankstipranks
Atossa Therapeutics announces resuts from Phase 2 KARISMA-Endoxifen study
PremiumThe FlyAtossa Therapeutics announces resuts from Phase 2 KARISMA-Endoxifen study
2M ago
Atossa Therapeutics announces three posters on Phase 2 EVANGELINE trial
Premium
The Fly
Atossa Therapeutics announces three posters on Phase 2 EVANGELINE trial
2M ago
Atossa Therapeutics presents data from research investigating Z-Endoxifen
Premium
The Fly
Atossa Therapeutics presents data from research investigating Z-Endoxifen
2M ago
Atossa Therapeutics appoints Claudia Lopez as VP, clinical development
PremiumThe FlyAtossa Therapeutics appoints Claudia Lopez as VP, clinical development
3M ago
Atossa repots topline data from the KARISMA-Endoxifen Phase 2 study
Premium
The Fly
Atossa repots topline data from the KARISMA-Endoxifen Phase 2 study
3M ago
Atossa preliminary analysis phase 2 trial of z-endoxifen met primary endpoint
Premium
The Fly
Atossa preliminary analysis phase 2 trial of z-endoxifen met primary endpoint
3M ago
Atossa, Quantum Health announce first patient dosed first patient in I-SPY 2
PremiumThe FlyAtossa, Quantum Health announce first patient dosed first patient in I-SPY 2
5M ago
Atossa announces appointment of Parks as VP, Investor, Public Relations
Premium
The Fly
Atossa announces appointment of Parks as VP, Investor, Public Relations
5M ago
Texas probes CenterPoint, Carlyle weighs Nobian sale: Monday Buzz
Premium
The Fly
Texas probes CenterPoint, Carlyle weighs Nobian sale: Monday Buzz
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100